Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials

INTRODUCTION: The Kidney Cancer Research Network of Canada (KCRNC) collaborated to prepare this consensus statement about the use of target agents as adjuvant therapy in patients with non-metastatic renal cell carcinoma (nmRCC) after nephrectomy. We reviewed the published data and performed a meta-a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Can Urol Assoc J
Auteurs principaux: Karakiewicz, Pierre I., Zaffuto, Emanuele, Kapoor, Anil, Basappa, Naveen S., Bjarnason, Georg A., Blais, Normand, Breau, Rodney H., Canil, Christina, Drachenberg, Darrel, Hotte, Sebastien J., Jeldres, Claudio, Jewett, Michael A.S., Kassouf, Wassim, Kollmannsberger, Christian, Lavallée, Luke T., Maloni, Ranjena, Patenaude, Francois, Pouliot, Frédéric, Reaume, M. Neil, Sabbagh, Robert, Shayegan, Bobby, So, Alan, Soulières, Denis, Tanguay, Simon, Wood, Lori, Bandini, Marco
Format: Artigo
Langue:Inglês
Publié: Canadian Medical Association 2018
Sujets:
Consensus Statement
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994982/
https://ncbi.nlm.nih.gov/pubmed/29877179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5187
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires